BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21692995)

  • 21. Evolution of myeloid leukemia in children with Down syndrome.
    Saida S
    Int J Hematol; 2016 Apr; 103(4):365-72. PubMed ID: 26910243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recommendations for Diagnosis and Treatment of Children with Transient Abnormal Myelopoiesis (TAM) and Myeloid Leukemia in Down Syndrome (ML-DS).
    Al-Kershi S; Golnik R; Flasinski M; Waack K; Rasche M; Creutzig U; Dworzak M; Reinhardt D; Klusmann JH
    Klin Padiatr; 2021 Nov; 233(6):267-277. PubMed ID: 34407551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two Novel
    Chukua K; Netsawang C; Padungthai K; Khetkham T; Chokevittaya P; Poonjearansilp O; Prachuktum S; Kositamongkol S; Techasatit W; Silapamongkolkul P; Satayasai W; Pusongchai T; Surapolchai P; Rojnueangnit K
    J Pediatr Genet; 2019 Dec; 8(4):187-192. PubMed ID: 31687255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving circulatory disturbance in transient abnormal myelopoiesis.
    Koga H; Miyako K; Suga N; Hidaka T; Takahashi N
    J Pediatr Hematol Oncol; 2012 May; 34(4):e149-51. PubMed ID: 22134612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome for Down syndrome patients with hematopoietic disorders.
    Li MJ; Lee NC; Yang YL; Yen HJ; Chang HH; Chien YH; Lu MY; Jou ST; Lin KH; Hwu WL; Lin DT
    J Formos Med Assoc; 2016 Feb; 115(2):94-9. PubMed ID: 26234152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of
    Barwe SP; Sebastian A; Sidhu I; Kolb EA; Gopalakrishnapillai A
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The paradox of Myeloid Leukemia associated with Down syndrome.
    Gupte A; Al-Antary ET; Edwards H; Ravindranath Y; Ge Y; Taub JW
    Biochem Pharmacol; 2022 Jul; 201():115046. PubMed ID: 35483417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and biological aspects of myeloid leukemia in Down syndrome.
    Boucher AC; Caldwell KJ; Crispino JD; Flerlage JE
    Leukemia; 2021 Dec; 35(12):3352-3360. PubMed ID: 34518645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation characterization in the GATA-1 gene in patients with Down's Syndrome diagnosed with transient abnormal myelopoiesis or acute megakaryoblastic leukemia.
    Mansini AP; Rubio PL; Rossi JG; Gallego MS; Medina A; Zubizarreta PA; Felice MS; Alonso CN
    Arch Argent Pediatr; 2013 Dec; 111(6):532-6. PubMed ID: 24196768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
    Brink DS
    Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PRAME immunohistochemical staining in transient abnormal myelopoiesis and myeloid leukemia associated with Down syndrome.
    Chisholm KM; Rivetta CV; Heerema-McKenney A
    Ann Clin Lab Sci; 2015; 45(2):121-7. PubMed ID: 25887863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
    Alford KA; Reinhardt K; Garnett C; Norton A; Böhmer K; von Neuhoff C; Kolenova A; Marchi E; Klusmann JH; Roberts I; Hasle H; Reinhardt D; Vyas P;
    Blood; 2011 Aug; 118(8):2222-38. PubMed ID: 21715302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitive detection of GATA1 mutations using complementary DNA-based analysis for transient abnormal myelopoiesis associated with the Down syndrome.
    Mizuta S; Yamane N; Mononobe S; Watanabe A; Kitamura R; Takahara T; Matsushima C; Yoshida A; Okamoto S; Tanaka K; Iwai A; Ikegawa A; Wada T; Usami I; Maihara T; Komai T; Heike T; Nishida Y; Kobayashi K
    Int J Lab Hematol; 2022 Apr; 44(2):349-355. PubMed ID: 34761527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient myeloproliferative disorder and GATA1 mutation in neonates with and without Down syndrome.
    Tsai MH; Hou JW; Yang CP; Yang PH; Chu SM; Hsu JF; Chiang MC; Huang HR
    Indian J Pediatr; 2011 Jul; 78(7):826-32. PubMed ID: 21287369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal selection in xenografted TAM recapitulates the evolutionary process of myeloid leukemia in Down syndrome.
    Saida S; Watanabe K; Sato-Otsubo A; Terui K; Yoshida K; Okuno Y; Toki T; Wang R; Shiraishi Y; Miyano S; Kato I; Morishima T; Fujino H; Umeda K; Hiramatsu H; Adachi S; Ito E; Ogawa S; Ito M; Nakahata T; Heike T
    Blood; 2013 May; 121(21):4377-87. PubMed ID: 23482930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly sensitive detection of GATA1 mutations in patients with myeloid leukemia associated with Down syndrome by combining Sanger and targeted next generation sequencing.
    Terui K; Toki T; Taga T; Iwamoto S; Miyamura T; Hasegawa D; Moritake H; Hama A; Nakashima K; Kanezaki R; Kudo K; Saito AM; Horibe K; Adachi S; Tomizawa D; Ito E
    Genes Chromosomes Cancer; 2020 Mar; 59(3):160-167. PubMed ID: 31606922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haematopoietic development and leukaemia in Down syndrome.
    Roberts I; Izraeli S
    Br J Haematol; 2014 Dec; 167(5):587-99. PubMed ID: 25155832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down syndrome presenting with different hematological manifestations: A case series of four cases.
    Shangpliang D; Dey B; Das J; Baishya P; Raphael V; Khonglah Y
    J Family Med Prim Care; 2020 May; 9(5):2569-2572. PubMed ID: 32754549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome.
    Garnett C; Cruz Hernandez D; Vyas P
    IUBMB Life; 2020 Jan; 72(1):119-130. PubMed ID: 31769932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of mutations in GATA1 gene using automated denaturing high-performance liquid chromatography and direct sequencing in children with Down syndrome.
    Amorim MR; Figueiredo AB; Splendore A; Magalhães IQ; Pombo-de-Oliveira MS; El-Jaick KB; D'andrea ML; Aquino J; Alencar DM; Brandalise SR; Burlemaqui L; Cardoso TC; Carvalho EG; Coser VM; Costa I; Dorea D; Drumond M; Lopes VG; Mendonça N; Lee ML; Lopes LF; Mendonça CM; Nogueira F; Pimenta F; Pinheiro VP; Da Silva DB; Sobral E; Vargas FR; Werneck F
    Leuk Lymphoma; 2009 May; 50(5):834-40. PubMed ID: 19452320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.